Clinical trials
Epilepsy trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 6 |
| Completed | 4 |
| Recruiting | 4 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 4 |
| Xijing Hospital | 3 |
| Shanghai Zhongshan Hospital | 2 |
| Beijing Sanbo Brain Hospital | 1 |
| Beijing Tiantan Hospital | 1 |
| China Academy of Chinese Medical Sciences | 1 |
| Second Affiliated Hospital of Guangzhou Medical University | 1 |
| Sichuan University | 1 |
| The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 1 |
| The University of Hong Kong | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsy | 18 |
| Aphasia | 1 |
| Autism Spectrum Disorder | 1 |
| Blepharospasm | 1 |
| Brain Diseases | 1 |
| Cerebral Palsy | 1 |
| Developmental Disabilities | 1 |
| Down Syndrome | 1 |
| Dysarthria | 1 |
| Epilepsy, Temporal Lobe | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.